Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
Open Access
- 21 July 2009
- Vol. 339 (jul21 1) , b2763
- https://doi.org/10.1136/bmj.b2763
Abstract
Objective To compare the effectiveness of oral quinine with that of artemether-lumefantrine in treating uncomplicated malaria in children. Design Randomised, open label effectiveness study. Setting Outpatient clinic of Uganda’s national referral hospital in Kampala. Participants 175 children aged 6 to 59 months with uncomplicated malaria. Interventions Participants were randomised to receive oral quinine or artemether-lumefantrine administered by care givers at home. Main outcome measures Primary outcomes were parasitological cure rates after 28 days of follow-up unadjusted and adjusted by genotyping to distinguish recrudescence from new infections. Secondary outcomes were adherence to study drug, presence of gametocytes, recovery of haemoglobin concentration from baseline at day 28, and safety profiles. Results Using survival analysis the cure rate unadjusted by genotyping was 96% for the artemether-lumefantrine group compared with 64% for the quinine group (hazard ratio 10.7, 95% confidence interval 3.3 to 35.5, P=0.001). In the quinine group 69% (18/26) of parasitological failures were due to recrudescence compared with none in the artemether-lumefantrine group. The mean adherence to artemether-lumefantrine was 94.5% compared with 85.4% to quinine (P=0.0008). Having adherence levels of 80% or more was associated with a decreased risk of treatment failure (0.44, 0.19 to 1.02, P=0.06). Adverse events did not differ between the two groups. Conclusions The effectiveness of a seven day course of quinine for the treatment of uncomplicated malaria in Ugandan children was significantly lower than that of artemether-lumefantrine. These findings question the advisability of the recommendation for quinine therapy for uncomplicated malaria in Africa. Trial registration ClinicalTrials.gov NCT00540202.Keywords
This publication has 31 references indexed in Scilit:
- Malaria case-management under artemether-lumefantrine treatment policy in UgandaMalaria Journal, 2008
- In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005Antimicrobial Agents and Chemotherapy, 2008
- Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese childrenMalaria Journal, 2007
- Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the CongoJournal of Clinical Microbiology, 2006
- Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-AmodiaquineAntimicrobial Agents and Chemotherapy, 2006
- Quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern SudanTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- A Randomized Comparison of Artesunate‐Atovaquone‐Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during PregnancyThe Journal of Infectious Diseases, 2005
- Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3‐day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in ZambiaTropical Medicine & International Health, 2005
- Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum MalariaAntimicrobial Agents and Chemotherapy, 2003
- Controlled Trial of 3-Day Quinine-Clindamycin Treatment versus 7-Day Quinine Treatment for Adult Travelers with Uncomplicated Falciparum Malaria Imported from the TropicsAntimicrobial Agents and Chemotherapy, 2001